Preferential effect of synchrotron microbeam radiation therapy on intracerebral 9L gliosarcoma vascular networks.
about
Early gene expression analysis in 9L orthotopic tumor-bearing rats identifies immune modulation in molecular response to synchrotron microbeam radiation therapySynchrotron microbeam irradiation induces neutrophil infiltration, thrombocyte attachment and selective vascular damage in vivoClinical applications of iron oxide nanoparticles for magnetic resonance imaging of brain tumors.Image-guided microbeam irradiation to brain tumour bearing mice using a carbon nanotube x-ray source array.Pilot study for compact microbeam radiation therapy using a carbon nanotube field emission micro-CT scannerPhysiologically gated microbeam radiation using a field emission x-ray source arrayIn situ biological dose mapping estimates the radiation burden delivered to 'spared' tissue between synchrotron X-ray microbeam radiotherapy tracks.Pencilbeam irradiation technique for whole brain radiotherapy: technical and biological challenges in a small animal modelBenchmarking and validation of a Geant4-SHADOW Monte Carlo simulation for dose calculations in microbeam radiation therapy.γ-H2AX as a marker for dose deposition in the brain of wistar rats after synchrotron microbeam radiation.Interactions between synchrotron radiation X-ray and biological tissues - theoretical and clinical significance.High resolution 3D imaging of synchrotron generated microbeams.NAD(+) administration significantly attenuates synchrotron radiation X-ray-induced DNA damage and structural alterations of rodent testesMicrobeam radiation therapy alters vascular architecture and tumor oxygenation and is enhanced by a galectin-1 targeted anti-angiogenic peptideRoles of oxidative stress in synchrotron radiation X-ray-induced testicular damage of rodents.Monte Carlo simulation of a compact microbeam radiotherapy system based on carbon nanotube field emission technology.A first generation compact microbeam radiation therapy system based on carbon nanotube X-ray technology.Roles of NAD (+) , PARP-1, and Sirtuins in Cell Death, Ischemic Brain Injury, and Synchrotron Radiation X-Ray-Induced Tissue Injury.Dose-rate plays a significant role in synchrotron radiation X-ray-induced damage of rodent testes.Imaging the microvessel caliber and density: Principles and applications of microvascular MRI.Monte Carlo dose enhancement studies in microbeam radiation therapy.The normal tissue effects of microbeam radiotherapy: What do we know, and what do we need to know to plan a human clinical trial?Computational modelling of the cerebral cortical microvasculature: effect of x-ray microbeams versus broad beam irradiation.Image guidance protocol for synchrotron microbeam radiation therapy.Identification of AREG and PLK1 pathway modulation as a potential key of the response of intracranial 9L tumor to microbeam radiation therapy.Increase of lifespan for glioma-bearing rats by using minibeam radiation therapy.Monte Carlo-based treatment planning system calculation engine for microbeam radiation therapy.Scatter factors assessment in microbeam radiation therapy.Neurocognitive sparing of desktop microbeam irradiation.Synchrotron X ray induced axonal transections in the brain of rats assessed by high-field diffusion tensor imaging tractographyIn vivo pink-beam imaging and fast alignment procedure for rat brain lesion microbeam radiation therapy.Line focus x-ray tubes-a new concept to produce high brilliance x-rays.Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.Dosimetry protocol for the preclinical trials in white-beam minibeam radiation therapy.Bystander effects in tumor-free and tumor-bearing rat brains following irradiation by synchrotron X-rays.Poly(ADP-ribose) polymerase activation mediates synchrotron radiation X-ray-induced damage of rodent testes by exacerbating DNA damage and apoptotic changes.Transfer of Minibeam Radiation Therapy into a cost-effective equipment for radiobiological studies: a proof of concept.Radiation therapy-induced metastasis: radiobiology and clinical implications.Hybrid dose calculation: a dose calculation algorithm for microbeam radiation therapy.X-Tream quality assurance in synchrotron X-ray microbeam radiation therapy.
P2860
Q28538112-33F58159-3A68-49DD-A3CC-76160E6816EDQ30812791-68314006-A8E5-405A-9D7E-A1EA97954FE2Q30930526-E85B99BC-31C9-441B-8218-4BA2A8EE3075Q33637481-D508E495-AE68-4045-915C-7A1F2B3EA489Q33655660-71D311A5-135F-4167-B2DC-8FE9FE0A4DE2Q33929890-F18DD1A3-BA77-4E2E-8CC0-10C44BDBDBE6Q34125308-8358D58B-6EFB-4116-B171-7654D6C13D8DQ34575860-6B845066-6326-4C33-88D7-D14E09B727ACQ35157169-F5B84944-5B9E-42A7-9F8F-71C1FE3EDD8AQ35208306-8AEA5DD6-1C4F-4CEA-97DB-B53C33423A57Q35591400-EE2E6879-7837-4BD5-A097-CC7EAB7CA44BQ35859651-769E33B5-DD51-42C0-B3B2-0CF74C37A651Q35894276-ACDA4633-395B-4AC9-9394-B665CE1A1288Q36082119-98229676-A180-4EA3-916D-D5ED34166A6CQ36111667-5C9AE6D6-9E95-42EF-8A78-6A41A7212090Q36139213-B8D47B33-9EFA-48AD-BD73-50D3A7409430Q37313568-5DFF3C5C-4C5B-47DE-A823-22F768D5F5A8Q37413322-5874A75C-A9EE-4811-AE91-4EC490AFB8C1Q37553607-E0216D5D-C6EE-412B-A06D-607CD2EAE25DQ38244289-5CE54A86-797B-4A7B-9F83-C89821FA46CDQ38774746-398FB041-7D7A-41E9-87BA-853DCAD72303Q38776742-273C1059-5C4D-4F9C-B8D7-AAF51E29DA94Q38883413-1F941895-B7E3-4663-B9D9-F4033A4AA9E5Q38903161-92E63C2F-8B2C-4D5F-8382-9CB66F455E22Q38941630-816A7F6A-6AB0-4B95-8854-1BC92422A17BQ39424865-482C0CC6-BBD1-499A-A565-51BF5FE06DDCQ39621240-FB5C25C2-2414-4DCC-AD5F-1C9E28C4FDD0Q39646188-B2E6F994-C16B-4976-809D-49FA9DD84F2FQ41365419-BA05227E-4BC3-4743-BD1B-BA3E404CC851Q41917570-A6C5E5F6-2182-4941-82D3-A59BF1D4DA48Q42578316-B3CB2434-11C5-4B7C-9501-7CDD34F6EDD3Q43102901-4A363EC7-70D8-430F-8F9B-E4BD0CBED4DDQ43447982-DEC7BD6E-BB39-4644-89D0-1920989DE5B3Q44135453-541391C6-DA61-454C-ABD5-4A18EE25FAF2Q44894382-03F5376F-4939-4682-A34C-A77E4620542BQ46914187-5E3F4DB8-2881-4F2C-9B3D-FBD9EF387818Q47099771-AC809D11-993D-4CBB-A427-F3C81262CD4AQ47438065-A94C6D15-24A0-45E7-BE12-781F4DC37A5FQ47565109-F6616BFA-571E-47A1-97A4-2D19BFB3262EQ47700035-851B22FD-5CBF-4255-8726-2D499617C118
P2860
Preferential effect of synchrotron microbeam radiation therapy on intracerebral 9L gliosarcoma vascular networks.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Preferential effect of synchro ...... gliosarcoma vascular networks.
@en
Preferential effect of synchro ...... gliosarcoma vascular networks.
@nl
type
label
Preferential effect of synchro ...... gliosarcoma vascular networks.
@en
Preferential effect of synchro ...... gliosarcoma vascular networks.
@nl
prefLabel
Preferential effect of synchro ...... gliosarcoma vascular networks.
@en
Preferential effect of synchro ...... gliosarcoma vascular networks.
@nl
P2093
P50
P1476
Preferential effect of synchro ...... gliosarcoma vascular networks.
@en
P2093
Alberto Bravin
Audrey Bouchet
Cathy Poillot
Chantal Rémy
Cécile Maisin
Elke Bräuer-Krisch
Géraldine Le Duc
Jean A Laissue
Luc Renaud
Raphaël Serduc
P304
P356
10.1016/J.IJROBP.2010.06.021
P407
P577
2010-12-01T00:00:00Z